比毛毛更可爱的是毛毛的月月

Recent Comments

  • Tina: 看冬蕾老师的文章已成习惯,感谢点点滴滴的温暖。
  • 择偶网: 新冠快点结束吧!
  • 淼淼: 一向觉得这种背影特别有爱……
  • 淼淼: 十年前的回忆!毛毛太棒啦,粉丝又多了一枚!拥有这么有才情的辣妈,月月童鞋是有多幸福……
  • DJ: Don’t comment on China’s regulatory environment –if you have to, positive and complementary remarks are always expected; i don't think so...
  • DJ: 就假装他们都很伟大....
  • DJ: 赞一个

Random Posts

Tag Cloud

Interview with Dr.Paul Pomerantz

2010/03/04 – 10:00 上午

I had a cheeringly meet with Dr.Paul Pomerantz, Drug Information Association (DIA)’s new worldwide executive director last week in Beijing.Here are my questions:

Q1, What do you think of the first DIA China annual meeting? How do you rate it given the 100 points scale?

Q2, Could you share with us your career story? What’s your best achievements till now? Is there any experience that can be taken as a turning point for your life?

Q3. In the past years, is there anyone or anything that brings a major influence to your life?

Q4, Why did you join in DIA? Currently, What’s your focus and challenge in your work? What’s your expectation to yourself?

Q5, You once said, “drug is not only making medicines”, When you were appointed to be the executive director of DIA, could you share your points of drug development? How to meet the unmet clinical needs with patient oriented?

Q6, Last year, DIA set up its office in China, what’s your strategy here in China? What’s your expectation to China market given its unique healthcare system and pharmaceutical industry?

Q7, With more and more MNCs set up its R&D center today in China, China begins to play a big role in new drug development globally, What do you think of this? What’s the strength and weakness of China compared with India in this area?

Q8, How do you comment yourself? What’s your principle as a teamleader?

Q9, Could you talk something about your dreams? What’s the present dream for you now?

发表评论

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>